Aj. Kee et al., Parenteral amino acid intake alters the anabolic actions of insulin-like growth factor I in rats, AM J P-ENDO, 40(1), 1999, pp. E63-E72
Citations number
47
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
The anabolic properties of insulin-like growth factor (IGF) I are attenuate
d by oral diets that are low in protein. However, it is not known whether p
arenteral nutrition (PN) providing a low amino acid (AA) input will influen
ce IGF-I action. With the use of a rat model, this study examined the inter
action between AA input (1.27 and 0.62 g N . kg body wt(-1) . 24 h(-1), AA.
and 1/2 AA groups, respectively) and recombinant human IGF-I (rhIGF-I, 2.5
mg . kg body wt(-1) . 24 h(-1)) infusion on the composition of the carcass
and organs and on plasma insulin, IGF-I, IGF-binding protein 1 (IGFBP-1),
and acid-labile subunit (ALS) concentrations. Carcass protein deposition on
ly occurred in the AA groups (P < 0.003) and was not influenced by administ
ration of rhIGF-I. However, visceral protein loss persisted in the AA group
but was prevented by rhIGF-I infusion. The changes in water content of the
carcass and the organs were generally in the expected proportion of normal
lean tissue. The accumulation of lipid that follows the infusion of the AA
-deficient PN was prevented by rhIGF-I infusion, which may indicate an impr
oved energy utilization. Neither serum insulin nor ALS concentrations were
influenced by the level of AA infusion but were reduced by rhIGF-I administ
ration. However, plasma IGF-I levels were elevated by higher AA infusion an
d by IGF-I administration. Also, IGFBP-1 concentrations were reduced by the
higher AA infusion and increased with rhIGF-I administration. Interestingl
y, there was a significant interaction effect between both of these influen
ces. It is concluded that free IGF-I concentration, which may be regulated
by IGFBP-1 through a direct effect of AAs on the liver, may have an importa
nt role in regulating anabolism in visceral and possibly skeletal tissue du
ring PN.